AMPH
Amphastar Pharmaceuticals Inc (AMPH) Q4 2025 Earnings Call Transcript
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Q4 2025 Earnings Call dated Feb. 26, 2026 Corporate Participants: Dan Dischner — Senior Vice…
Amphastar Pharmaceuticals Inc (AMPH) Sec Form 8K
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Sec Form 8K
Amphastar Pharmaceuticals Inc (AMPH) Sec Form 8K
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Sec Form 8K
Amphastar Pharmaceuticals Inc (AMPH) Sec Form 10K
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Sec Form 10K
Amphastar Pharmaceuticals Inc (AMPH) Sec Form 8K
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Sec Form 8K
Amphastar Pharmaceuticals Inc (AMPH) Q4 2025 Earnings Results
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Q4 2025 Earnings Release
Amphastar Pharmaceuticals Inc (AMPH) Amphastar Announces FDA Approval for Ipratropium Bromide HFA
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) FY 2026 Other Release
Amphastar Pharmaceuticals Inc (AMPH) Q4 2025 Earnings Call
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Q4 2025 Earnings Conference
Amphastar Pharmaceuticals Inc (AMPH) Q4 2025 Earnings Announcement
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Q4 2025 Earnings Announcement